This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Kither Biotech Srl, Universita Degli Studi Del Piemonte Orientale "Amedeo Avogadro", Universitá Degli Studi Di Torino. Active years: 2012-2022.
Company Filing History:
3 out of 3 
1 out of 4 
1 out of 16 Years Active: 2012-2022
Title: Emilio Hirsch: Innovator in Respiratory Treatments
Introduction
Emilio Hirsch is a notable inventor based in Turin, Italy. He has made significant contributions to the field of respiratory system diseases through his innovative research and development. With a total of 5 patents, Hirsch has established himself as a key figure in the biotechnology sector.
Latest Patents
Hirsch's latest patents include a PI3K gamma inhibitor peptide designed for the treatment of respiratory system diseases. This fusion peptide comprises an amino acid sequence defined in SEQ ID No.: 1 or a related homolog with at least 90% identity to SEQ ID No.: 1, which has the ability to inhibit the kinase-independent function of PI3Kγ. Additionally, it includes a peptide capable of penetrating a cell. Another significant patent is the PI3Kγ inhibitor peptide, which shares similar characteristics and aims to provide therapeutic benefits for respiratory conditions.
Career Highlights
Throughout his career, Emilio Hirsch has worked with prominent organizations such as Kither Biotech Srl and Università Degli Studi Di Torino. His work in these institutions has allowed him to advance his research and contribute to the development of innovative treatments.
Collaborations
Hirsch has collaborated with esteemed colleagues, including Alessandra Ghigo and Elisa Ciraolo. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of respiratory health.
Conclusion
Emilio Hirsch's contributions to the field of respiratory treatments through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science, particularly in the treatment of respiratory diseases.